Search research articles
Contact Us
Filters
Showing results (151-160 of 164) with videos related to
Page
of 17
Sort By:
Journal of Viral Hepatitis
|
October 31, 2009
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa
M E Mendy, T Welzel, O A Lesi, et al.
Oncogene
|
May 10, 2006
Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB
V Benoit, E de Moraes, N A Dar, et al.
Cancer Research
|
September 18, 2001
Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions
D M DeMarini, S Landi, D Tian, et al.
British Journal of Cancer
|
June 26, 2008
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
A Bengochea, M M de Souza, L Lefrançois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2017
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer
M-S Tsao, G Le Teuff, F A Shepherd, et al.
Carcinogenesis
|
December 4, 2009
TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America
K Szymańska, J E Levi, A Menezes, et al.
Journal De Pharmacie De Belgique
|
May 4, 2013
[Rivaroxaban: Xarelto--recommendations for pharmacists]
J Douxfils, S Michel, C Beauloye, et al.
Oncogene
|
June 7, 2011
TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression
C Ruptier, A De Gaspéris, S Ansieau, et al.
Cancer Letters
|
February 9, 2010
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe
K Szymańska, L E Moore, N Rothman, et al.
BMJ (Clinical Research Ed.)
|
February 1, 2005
Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study
P Vineis, L Airoldi, F Veglia, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 164) with videos related to
Sort By:
Page
of 17
Journal of Viral Hepatitis
|
October 31, 2009
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa
M E Mendy, T Welzel, O A Lesi, et al.
Oncogene
|
May 10, 2006
Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB
V Benoit, E de Moraes, N A Dar, et al.
Cancer Research
|
September 18, 2001
Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions
D M DeMarini, S Landi, D Tian, et al.
British Journal of Cancer
|
June 26, 2008
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
A Bengochea, M M de Souza, L Lefrançois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2017
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer
M-S Tsao, G Le Teuff, F A Shepherd, et al.
Carcinogenesis
|
December 4, 2009
TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America
K Szymańska, J E Levi, A Menezes, et al.
Journal De Pharmacie De Belgique
|
May 4, 2013
[Rivaroxaban: Xarelto--recommendations for pharmacists]
J Douxfils, S Michel, C Beauloye, et al.
Oncogene
|
June 7, 2011
TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression
C Ruptier, A De Gaspéris, S Ansieau, et al.
Cancer Letters
|
February 9, 2010
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe
K Szymańska, L E Moore, N Rothman, et al.
BMJ (Clinical Research Ed.)
|
February 1, 2005
Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study
P Vineis, L Airoldi, F Veglia, et al.
Page
of 17